BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Oct. 20, 2009
View Archived Issues
Triamcinolone acetonide phase III SCORE study results in macular edema reported
Read More
Novo Nordisk to assess insulin analogue NN-1250 in phase III trials in type 1 and 2 diabetes
Read More
Inhaled AIR-645 well tolerated in phase I study
Read More
Phase II data for p53-SLP vaccine in ovarian cancer reported
Read More
BIBF-1120 maintenance therapy may delay disease progression in ovarian cancer
Read More
Ono's oral antidiabetic Glactiv tablet approved in Japan
Read More
AstraZeneca submits MAA in Europe for Vimovo
Read More
FDA approves GSK's cervical cancer vaccine for girls and young women aged 10-25 years
Read More
FDA approves Crestor for pediatric heterozygous familial hypercholesterolemia
Read More
AstraZeneca and Astellas' Symbicort Turbuhaler approved in Japan for asthma
Read More
FDA authorizes Diatherix Laboratories' H1N1-09 influenza test for emergency use
Read More
Transgenomic licenses Cold-PCR technology from Dana-Farber Cancer Institute
Read More
TcLand Expression starts study of K-RejX test in kidney transplant recipients at risk of CAMR
Read More
Med BioGene reports results from validation study of LungExpess Dx in NSCLC
Read More
Epigenomics launches Epi proColon diagnostic blood test for colorectal cancer in Europe
Read More
Vitae Pharmaceuticals describes 11beta-HSD1 inhibitors for the treatment of diabetes
Read More
Novel oncolytic compounds disclosed by Columbia University
Read More
Gruenenthal claims ORL1 and mu-opioid receptor ligands for the treatment of pain
Read More
Takeda receives Japanese approval for additional indication for Basen
Read More
FDA approves Elitek for management of plasma uric acid levels in cancer patients
Read More
Rexahn reports topline phase IIa data for Serdaxin in major depressive disorder
Read More
K-101 topical solution eradicates infection in adults with distal subungual onychomycosis
Read More
Dainippon Sumitomo's Miripla granted Japanese manufacturing and marketing approval
Read More
GnRH antagonist elagolix sodium improves endometriosis symptoms in Petal study
Read More
Diabetes candidate drug DSP-7238 shows selective and sustained DPP IV inhibition
Read More
Patupilone active against breast cancer brain metastases
Read More
BNC-210 exhibits anxiolytic and antidepressant activity in preclinical studies in rats
Read More